Top Medical News
Pearl Toh, 4 hours ago
The risk of major stroke at 30 days was higher after surgical aortic valve replacement (SAVR) than transfemoral-transcatheter AVR (TF-TAVR) in patients with similar risk profile, according to data from the PARTNER* trials.
5 hours ago
Consuming soft drinks during and after exercise under heat stress may lead to acute kidney injury, a new study has found.
Roshini Claire Anthony, 9 hours ago

Patients with obesity have an elevated risk of intra- and postoperative complications following surgical treatment for inflammatory bowel disease (IBD), according to a presentation at the recent Advances in Inflammatory Bowel Disease meeting (AIBD 2018).

9 hours ago
Infertility in reproductive-aged women is associated with greater risks of metabolic syndrome and cardiovascular disease, a study has found.
10 hours ago
Rates of total hip arthroplasty (THA) increased twofold over the years in older patients with ankylosing spondylitis (AS), outpacing that in the general population, according to a study. There has also been a substantial increase in rates of total knee arthroplasty (TKA) in older patients with AS.
Stephen Padilla, 11 hours ago
A recent study has shown the efficacy and safety of radio frequency ablation (RFA) in small renal masses, particularly those <3 cm in diameter, providing good oncologic outcomes at long-term follow-up.
Jairia Dela Cruz, 12 hours ago
Girls who are overweight or tall at ages 7–13 years are at increased risk of ovarian cancer, a study reports. This highlights the importance of a healthy body size and growth in reducing the risk of the disease.
Special Reports
17 Jan 2019
At the recent 34th Annual Congress of the Malaysian Society of Nephrology, Dr Kyriaki Stamatelou reviewed the role of alfacalcidol (One-Alpha®; LEO Pharma) – a vitamin D analogue – in the prevention and management of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD).
20 Dec 2018
International travellers have a potential for exposure to diseases outside their home countries and may carry nonendemic diseases between countries.1
Dr. Choo Gim Hooi, Assoc Prof. Pattarapong Makarawate, Dr. Krisada Sastravaha, 17 Dec 2018
Coronary artery disease (CAD) is a leading cause of mortality and morbidity globally and its burden is expected to increase due to the rising prevalence of risk factors such as hypertension, diabetes, and dyslipidaemia. In conjunction with the 23rd ASEAN Federation of Cardiology Congress held in Bangkok, Thailand, Menarini organized a lunch symposium and product theatre to discuss the significance of optimal medical therapy (OMT) in the management of stable CAD, with a focus on the role of ranolazine (Ranexa®).
17 Dec 2018
At the 3rd National Pain Free Conference held at Putrajaya, Dr Ho Kok Yuen spoke on the role of nonsteroidal anti-inflammatory drugs (NSAIDs) in the management of osteoarthritis (OA) and important considerations when using NSAIDs, especially among patients with risk factors for NSAID toxicity.
17 Dec 2018
At the 40th Malaysian Paediatric Association Annual Congress held on 6 September 2018 at the Ipoh Convention Centre, Dr Yong Junina Fadzil discussed the applications of a hexavalent vaccine in optimizing paediatric vaccination schedules. Meanwhile, Dato’ Dr Musa Mohd Nordin shared his insights into the paediatric influenza ‘landscape’ in the region and highlighted the importance of regularly vaccinating paediatric patients.
30 Nov 2018
Despite risk factors for cardiovascular disease (CVD) being similar around the world, the burden of CVD is not uniform across nations. Furthermore, CVD-related death in low- to middle-income countries (LMICs) has increased by two-thirds in the last 30 years, and now account for a whopping 80% of global deaths due to CVD.
30 Nov 2018
Poor adherence to statin therapy is leaving many patients with dyslipidaemia at high risk of potentially life-threatening cardiovascular events. Statins are the current standard of care for reducing the risk of cardiovascular disease in these patients and for improving life expectancy, with possible economic benefits for healthcare systems too. However, many patients with dyslipidaemia are not achieving or maintaining treatment targets because they fail to stick to their prescribed statin therapy. An article co-authored by lipidologist Peter Lansberg, and published in Vascular Health and Risk Management, considers this issue and reviews approaches to overcome non-adherence.
Conference Reports
Elaine Soliven, 10 Jan 2019
Younger women with breast cancer who had a mastectomy demonstrated a worse quality of life (QoL) compared with those who underwent breast-conserving surgery (BCS), according to a study presented at SABCS 2018.
Roshini Claire Anthony, 09 Jan 2019

Women with metabolic syndrome who are diagnosed with early breast cancer may have poorer survival outcomes, according to a study from Italy presented as a poster at SABCS 2018.

Roshini Claire Anthony, 08 Jan 2019

Patients with symptomatic multiple myeloma (MM) following induction and conditioning therapy and autologous stem cell transplant (ASCT) may derive survival benefit from maintenance therapy with ixazomib, according to the phase III TOURMALINE-MM3* trial.

Pank Jit Sin, 07 Jan 2019
Switching from animal to plant-based proteins in one’s daily diet is linked to many benefits, one of which is the management of type 2 diabetes mellitus, says a researcher. 
Pank Jit Sin, 07 Jan 2019
Type 2 diabetes is closely linked to obesity, which in turn, increases the risk for cardiovascular diseases (which includes mainly heart disease and stroke), muscle and bone diseases; and cancers. Obesity-related cancers include breast, endometrial, ovarian, colorectal, pancreatic, renal, liver and gallbladder cancer. [Lancet 2008;371(9612):569–578]

Roshini Claire Anthony, 28 Dec 2018

The addition of daratumumab to lenalidomide and dexamethasone improved progression-free survival (PFS) in patients newly diagnosed with multiple myeloma (MM) who were ineligible for a stem cell transplant, according to interim results of the phase III multinational MAIA* trial.

Audrey Abella, 28 Dec 2018
Use of a scalp cooling device is effective in reducing alopecia or hair loss in patients with breast cancer who are undergoing neoadjuvant/adjuvant chemotherapy including anthracyclines* and taxanes**, according to studies presented at SABCS 2018.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download